4RVI
Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with non-peptidic inhibitor, GRL0519
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 21-ID-F |
Synchrotron site | APS |
Beamline | 21-ID-F |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2012-03-03 |
Detector | RAYONIX MX-225 |
Wavelength(s) | 0.98 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 58.960, 64.730, 100.740 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 32.961 - 1.990 |
R-factor | 0.2336 |
Rwork | 0.231 |
R-free | 0.27740 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.009 |
RMSD bond angle | 1.247 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | MOLREP |
Refinement software | PHENIX ((phenix.refine: 1.9_1692)) |
Data quality characteristics
Overall | |
Low resolution limit [Å] | 33.580 |
High resolution limit [Å] | 1.950 |
Rmerge | 0.134 |
Number of reflections | 28838 |
<I/σ(I)> | 8.6 |
Completeness [%] | 99.9 |
Redundancy | 7.8 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 5 | 298 | 3M Ammonium sulfate + 0.1 M Citric acid, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K |